1. Home
  2. CDTX vs PEB Comparison

CDTX vs PEB Comparison

Compare CDTX & PEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDTX
  • PEB
  • Stock Information
  • Founded
  • CDTX 2012
  • PEB 2009
  • Country
  • CDTX United States
  • PEB United States
  • Employees
  • CDTX N/A
  • PEB N/A
  • Industry
  • CDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • PEB Real Estate Investment Trusts
  • Sector
  • CDTX Health Care
  • PEB Real Estate
  • Exchange
  • CDTX Nasdaq
  • PEB Nasdaq
  • Market Cap
  • CDTX 980.1M
  • PEB 1.1B
  • IPO Year
  • CDTX 2015
  • PEB 2009
  • Fundamental
  • Price
  • CDTX $63.31
  • PEB $10.03
  • Analyst Decision
  • CDTX Strong Buy
  • PEB Hold
  • Analyst Count
  • CDTX 11
  • PEB 7
  • Target Price
  • CDTX $52.11
  • PEB $11.83
  • AVG Volume (30 Days)
  • CDTX 659.9K
  • PEB 2.2M
  • Earning Date
  • CDTX 08-07-2025
  • PEB 07-29-2025
  • Dividend Yield
  • CDTX N/A
  • PEB 0.40%
  • EPS Growth
  • CDTX N/A
  • PEB N/A
  • EPS
  • CDTX N/A
  • PEB N/A
  • Revenue
  • CDTX $302,000.00
  • PEB $1,469,933,000.00
  • Revenue This Year
  • CDTX N/A
  • PEB $1.70
  • Revenue Next Year
  • CDTX N/A
  • PEB $2.84
  • P/E Ratio
  • CDTX N/A
  • PEB N/A
  • Revenue Growth
  • CDTX N/A
  • PEB 2.00
  • 52 Week Low
  • CDTX $10.14
  • PEB $7.42
  • 52 Week High
  • CDTX $66.95
  • PEB $15.12
  • Technical
  • Relative Strength Index (RSI)
  • CDTX 70.66
  • PEB 43.38
  • Support Level
  • CDTX $60.71
  • PEB $10.44
  • Resistance Level
  • CDTX $66.95
  • PEB $11.21
  • Average True Range (ATR)
  • CDTX 4.25
  • PEB 0.39
  • MACD
  • CDTX -0.39
  • PEB -0.10
  • Stochastic Oscillator
  • CDTX 79.25
  • PEB 14.75

About CDTX Cidara Therapeutics Inc.

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

About PEB Pebblebrook Hotel Trust of Beneficial Interest

Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,933 rooms across 46 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.

Share on Social Networks: